Literature DB >> 1420849

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.

P M Odell1, K M Anderson, R B D'Agostino.   

Abstract

The accelerated failure time regression model is most commonly used with right-censored survival data. This report studies the use of a Weibull-based accelerated failure time regression model when left- and interval-censored data are also observed. Two alternative methods of analysis are considered. First, the maximum likelihood estimates (MLEs) for the observed censoring pattern are computed. These are compared with estimates where midpoints are substituted for left- and interval-censored data (midpoint estimator, or MDE). Simulation studies indicate that for relatively large samples there are many instances when the MLE is superior to the MDE. For samples where the hazard rate is flat or nearly so, or where the percentage of interval-censored data is small, the MDE is adequate. An example using Framingham Heart Study data is discussed.

Mesh:

Year:  1992        PMID: 1420849

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  39 in total

Review 1.  Rank estimation of log-linear regression with interval-censored data.

Authors:  Linxiong Li; Zongwei Pu
Journal:  Lifetime Data Anal       Date:  2003-03       Impact factor: 1.588

2.  Application of survival analysis methodology to the quantitative analysis of LC-MS proteomics data.

Authors:  Carmen D Tekwe; Raymond J Carroll; Alan R Dabney
Journal:  Bioinformatics       Date:  2012-05-24       Impact factor: 6.937

3.  Estimation of survival functions in interval and right censored data using STD behavioural diaries.

Authors:  Jaroslaw Harezlak; Wanzhu Tu
Journal:  Stat Med       Date:  2006-12-15       Impact factor: 2.373

4.  Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

Authors:  Maurice W Dysken; Mary Sano; Sanjay Asthana; Julia E Vertrees; Muralidhar Pallaki; Maria Llorente; Susan Love; Gerard D Schellenberg; J Riley McCarten; Julie Malphurs; Susana Prieto; Peijun Chen; David J Loreck; George Trapp; Rajbir S Bakshi; Jacobo E Mintzer; Judith L Heidebrink; Ana Vidal-Cardona; Lillian M Arroyo; Angel R Cruz; Sally Zachariah; Neil W Kowall; Mohit P Chopra; Suzanne Craft; Stephen Thielke; Carolyn L Turvey; Catherine Woodman; Kimberly A Monnell; Kimberly Gordon; Julie Tomaska; Yoav Segal; Peter N Peduzzi; Peter D Guarino
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

5.  A study of interval censoring in parametric regression models.

Authors:  J K Lindsey
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

6.  Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.

Authors:  Omid Beiki; Paolo Frumento; Matteo Bottai; Ali Manouchehrinia; Jan Hillert
Journal:  JAMA Neurol       Date:  2019-06-01       Impact factor: 18.302

7.  Maximum likelihood estimation for the proportional odds model with mixed interval-censored failure time data.

Authors:  Liang Zhu; Xingwei Tong; Dingjiao Cai; Yimei Li; Ryan Sun; Deo K Srivastava; Melissa M Hudson
Journal:  J Appl Stat       Date:  2020-07-13       Impact factor: 1.404

8.  A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data.

Authors:  Lianming Wang; Christopher S McMahan; Michael G Hudgens; Zaina P Qureshi
Journal:  Biometrics       Date:  2015-09-22       Impact factor: 2.571

9.  Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

Authors:  Maurice W Dysken; Peter D Guarino; Julia E Vertrees; Sanjay Asthana; Mary Sano; Maria Llorente; Muralidhar Pallaki; Susan Love; Gerard D Schellenberg; J Riley McCarten; Julie Malphurs; Susana Prieto; Peijun Chen; David J Loreck; Sara Carney; George Trapp; Rajbir S Bakshi; Jacobo E Mintzer; Judith L Heidebrink; Ana Vidal-Cardona; Lillian M Arroyo; Angel R Cruz; Neil W Kowall; Mohit P Chopra; Suzanne Craft; Stephen Thielke; Carolyn L Turvey; Catherine Woodman; Kimberly A Monnell; Kimberly Gordon; Julie Tomaska; Govind Vatassery
Journal:  Alzheimers Dement       Date:  2013-04-11       Impact factor: 21.566

10.  Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

Authors:  Neil H White; Wanjie Sun; Patricia A Cleary; William V Tamborlane; Ronald P Danis; Dean P Hainsworth; Matthew D Davis
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.